172
Views
9
CrossRef citations to date
0
Altmetric
Research Article

In vitro and in vivo evaluations of PLGA microsphere vaccine formulations containing pDNA coexpressing Hepatitis B surface antigen and Interleukin-2

, , &
Pages 48-56 | Received 25 Mar 2009, Accepted 30 Mar 2009, Published online: 18 Jan 2010

References

  • Ando S, Putnam D, Pack DW, Langer R. PLGA microspheres containing plasmid DANN: Preservation of supercoiled DNA via cryopreparation and carbohydrate stabilization. J Pharm Sci 1998; 88: 126–130
  • Boyer JD, Ugen KE, Wang B, Agadjanyani MG, Gilbert L, Bagarazzi ML, et al. Protection of chimpanzees from high-dose heterologous HIV-I challenge by DNA vaccination. Nature Med 1997; 3: 526–532
  • Choudary S, Ravikumar P, Ashok Kumar C, Suryanarayana VVS, Reddy GR. Enhanced immune response of DNA vaccine (VP1-pCDNA) adsorbed on cationic PLG for foot and mouth disease in guinea pig. Virus Genes 2008; 37: 81–87
  • Chow YH, Huang WL, Chi WK, Chu YD, Tao MH. Improvement of Hepatitis B virus DNA vaccines by plasmids coexpressing Hepatitis B surface antigen and interleukin-2. J Virol 1997; 71: 169–179
  • Coelho-Castelo AA, Santos Junior RR, Bonato VDL, Jamur MC, Oliver C, Silva CL. B-lymphocytes in bone marrow or lymph nodes can take up plasmid DNA after intramuscular delivery. Human Gene Ther 2003; 14: 1279–1285
  • Dastan T, Turan K. In vitro characterization and delivery of chitosan-DNA microparticles into mammalian cells. J Pharm Pharm Sci 2004; 7: 205–214
  • Davis HL, Michel ML, Whalen RG. DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody. Human Molec Genet 1993; 2: 1847–1851
  • Denis-Mize KS, Dupuis M, MacKichan ML, Singh M, Doe B, O’Hagan D, et al. Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cells. Gene Therapy 2000; 7: 2105–2112
  • Dietrich G, Spreng S, Favre D, Viret JF, Guzman CA. Live attenuated bacteria as vectors to deliver plasmid DNA vaccines. Curr Opin Molec Ther 2003; 5: 10–19
  • Diez S, Tros de Ilarduya C. Versatility of biodegredabla poly(D;L-lactic-co-glycolic acid) microspheres for plasmid DNA delivery. Eur J Pharm Biopharm 2006; 63: 188–197
  • Espuelay S, Irache JM, Gamazo C. Synthetic particulate antigen delivery systems for vaccination. Immunologia 2005; 24: 208–223
  • Fu K, Pack DW, Klibanow AM, Langer R. Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres. Pharm Res 2000; 17: 100–106
  • Garg S, Oran A, Wajchman J, Sasaki S, Maris CH, Kapp JA, et al. Genetic tagging shows increased frequency and longevity of antigen-presenting, skin derived dendritic cells in vivo. Nature Immunol 2003; 4: 907–912
  • Gregoriadis G, Saffie R, Souza JB. Mediated DNA vaccination. FEBS Lett 1997; 402: 107–110
  • He XW, Wang F, Jiang L, Li J, Liu SK, Xiao ZY, et al. Induction of mucosal and systemic immune response by single-dose oral immunization with biodegradable microparticles containing DNA encoding HBsAg. J Gen Virol 2005; 86: 601–610
  • Hedley ML, Gurley J, Urban R. Microspheres containing plasmid encoded antigens elicit cytotoxic T-cell responses. Nature Med 1998; 4: 365–368
  • Jaganathan KS, Vyas SP. Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally. Vaccine 2006; 24: 4201–4211
  • Jeffry H, Stanley SS, O’Hagan DT. The preparation and characterization of poly(lactide-co-glycolide) microparticles. II. The entrapment of a model protein using a (water-in-oil)-in water emulsion solvent evaporation technique. Pharm Res 1993; 10: 362–368
  • Jones DH, Corris S, McDonald S, Clegg JCS, Farrar GH. Poly (D,L-Lactic-co-glycolide) encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration. Vaccine 1997; 15: 814–817
  • Klencke B, Matijevic M, Urban RG, Lathey JL, Hedley ML, Berry M, et al. Encapsulated plasmid DNA treatment for human papilloma virus 16-associated anal displasia: A phase I study of ZYC101. Clin Cancer Res 2002; 8: 1028–1037
  • McClements WL, Armstrong ME, Keys RD, Liu MA. Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease. Proc Natl Acad Sci USA 1996; 93: 11414–11420
  • Mok H, Park TG. Direct plasmid DNA encapsulation within PLGA nanospheres by single oil-in-water emulsion method. Eur J Pharm Biopharm 2008; 68: 105–111
  • O’Donnell PB, McGinity JW. Preparation of microspheres by the solvent evaporation technique. Adv Drug Deliv Rev 1997; 28: 25–42
  • Pandit S, Cevher E, Zariwala MG, Somavarapu S, Alpar HO. Enhancement of immune response of HBsAg loaded poly (L-lactic acid) microspheres against hepatitis B through incorporation of alum and chitosan. J Microencapsulation 2007; 24: 539–552
  • Rosca ID, Watari I, Uo M. Microparticle formation and its mechanism in single and double emulsion solvent evaporation. J Contr Rel 2004; 99: 271–280
  • Sambrook J, Fritsch EF, Maniatis T. Plasmid vectors. Molecular cloning, J Sambrook, EF Fritsch, T Maniatis. Cold spring harbor laboratory press, New YorkUSA 1989; 1.33–1.40
  • Shi L, Caulfield MJ, Chern RT, Wilson RA, Sanyal G, Volkin DB. Pharmaceutical and immunological evaluation of a single-shot hepatitis B vaccine formulated with PLGA microspheres. J Pharm Sci 2002; 91: 1019–1035
  • Singh M, Briones M, Ott G, O’Hagan D. Cationic microparticles: a potent delivery system for DNA vaccines. Proc Natl Acad Sci USA 2000; 97: 811–816
  • Tang DC, DeVith M, Johmston SA. Genetic immunization is a simple method for eliciting an immune responce. Nature 1992; 356: 152–154
  • Tinsley-Brown AM, Fretwell R, Dowsett AB, Davis SL, Farrar GH. Formulation of poly (D,L-Lactic-co-glycolic acid) microparticles for rapid plasmid DNA delivery. J Contr Rel 2000; 66: 229–241
  • Tuttenberg A, Jonuleit H, Tüting T, Brück J, Knop J, Enk AH. Priming of T cells with Ad-transduced DC followed by expansion with peptide-pulsed DC significantly enhances the induction of tumor specific CD8 T cells: Implications for an efficient vaccination strategy. Gene Ther 2003; 10: 243–250
  • Ulmar JB, Donelly JJ, Parker SE, Rhode GH, Felgner PL, Dwarki V, et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 1993; 259: 1745–1749
  • Walter E, Moelling K, Pavlovic J, Merkle HP. Microencapsulation of DNA using poly(D,L-lactic-co-glycolide): Stability issues and release characteristics. J Contr Rel 1999; 61: 361–374
  • Wang D, Robinson DR, Kwon GS, Samuel J. Encapsulation of plasmid DNA in biodegradable poly (D,L-Lactic-co-glycolic acid) microspheres as a novel approach for immunogene delivery. J Contr Rel 1999; 57: 9–18
  • Wang S, Liu X, Fisher K, Smith JG, Chen F, Tobery TW, et al. Enhanced type I immune response to a hepatitis B DNA vaccine by formulation with calcium or aluminium phosphate. Vaccine 2000; 18: 1227–1235
  • Wolff JA, Dowty ME, Jiao S, Repetto G, Berg RK, Ludtke JJ, et al. Expression of naked plasmids by cultured myotubes and entry of plasmids into T tubules and caveolae of mammalian skeletal muscle. J Cell Sci 1992; 103: 1249–1259
  • Wolff JA, Malona RW, Williams P, Chong W, Acsadi G, Jani A, et al. Direct gene transfer into mouse muscle in vivo. Science 1990; 247: 1465–1468
  • Zhang W, Dong SF, Sun SH, Wang Y, Li GD, Qu D. Coimmunization with IL-15 plasmid enhances the longevity of CD8 T cells induced by DNA encoding hepatitis B virus core antigen. W J Gastroenterol 2006; 12: 4727–4735

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.